PHASE-II EVALUATION OF DIANHYDROGALACTITOL IN THE TREATMENT OF ADVANCED ENDOMETRIAL ADENOCARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

被引：0
|
作者：
STEHMAN, FB
BLESSING, JA
DELGADO, G
LOUKA, M
机构：
[1] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,GYNECOL ONCOL GRP,HEADQUARTERS OFF,PHILADELPHIA,PA 19107
[2] GEORGETOWN UNIV HOSP,WASHINGTON,DC 20007
[3] HAHNEMANN MED COLL & HOSP,PHILADELPHIA,PA 19102
[4] INDIANA UNIV,MED CTR,INDIANAPOLIS,IN 46204
[5] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263
来源：
CANCER TREATMENT REPORTS | 1983年 / 67卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：737 / 738
页数：2
相关论文
共 50 条
  • [41] A PHASE-II STUDY OF FAZARABINE (NSC-281272) IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    MANETTA, A
    BLESSING, JA
    MANN, WJ
    SMITH, DM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (05): : 439 - 440
  • [42] A GYNECOLOGIC-ONCOLOGY-GROUP PHASE-II STUDY OF AMONAFIDE (NSC-308847) IN EPITHELIAL OVARIAN-CANCER
    ASBURY, RF
    BLESSING, JA
    LOOK, KY
    CLARKEPEARSON, D
    HOMESLEY, HD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (06): : 529 - 531
  • [43] AMINOTHIADIAZOLE IN THE TREATMENT OF ADVANCED LEIOMYOSARCOMA OF THE UTERINE CORPUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    ASBURY, R
    BLESSING, JA
    SMITH, DM
    CARSON, LF
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (05): : 397 - 399
  • [44] PHASE-II TRIAL OF DIANHYDROGALACTITOL IN ADVANCED RENAL-CELL CARCINOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    RATANATHARATHORN, V
    BAKER, LH
    BALDUCCI, L
    TALLEY, RW
    HOOGSTRATEN, B
    CANCER TREATMENT REPORTS, 1982, 66 (05): : 1231 - 1232
  • [45] ICRF-159 (RAZOXANE) IN PATIENTS WITH ADVANCED ADENOCARCINOMA OF THE ENDOMETRIUM - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    HOMESLEY, HD
    BLESSING, JA
    CONROY, J
    HATCH, K
    DISAIA, PJ
    TWIGGS, LB
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01): : 15 - 17
  • [46] A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study
    Leslie, Kimberly K.
    Sill, Michael W.
    Fischer, Edgar
    Darcy, Kathleen M.
    Mannel, Robert S.
    Tewari, Krishnansu S.
    Hanjani, Parviz
    Wilken, Jason A.
    Baron, Andre T.
    Godwin, Andrew K.
    Schilder, Russell J.
    Singh, Meenakshi
    Maihle, Nita J.
    GYNECOLOGIC ONCOLOGY, 2013, 129 (03) : 486 - 494
  • [47] A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study
    Coleman, Robert L.
    Sill, Michael W.
    Lankes, Heather A.
    Fader, Amanda Nickles
    Finkler, Neil J.
    Hoffman, James S.
    Rose, Peter G.
    Sutton, Gregory P.
    Drescher, Charles W.
    McMeekin, D. Scott
    Hu, Wei
    Deavers, Michael
    Godwin, Andrew K.
    Alpaugh, R. Katherine
    Sood, Anil K.
    GYNECOLOGIC ONCOLOGY, 2012, 127 (03) : 538 - 543
  • [48] TENIPOSIDE (VM-26) IN PATIENTS WITH ADVANCED ENDOMETRIAL CARCINOMA - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP
    MUSS, HB
    BUNDY, BN
    ADCOCK, L
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (01): : 36 - 37
  • [49] PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH ADVANCED METASTATIC OR RECURRENT ENDOMETRIAL ADENOCARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    MALVIYA, VK
    LIU, PY
    OTOOLE, R
    ALBERTS, DS
    SURWIT, E
    ROSENOFF, S
    WARD, JH
    YU, A
    OSULLIVAN, J
    CRAIG, JB
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (01): : 37 - 40
  • [50] A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
    Bender, David
    Sill, Michael W.
    Lankes, Heather A.
    Reyes, Henry D.
    Darus, Christopher J.
    Delmore, James E.
    Rotmensch, Jacob
    Gray, Heidi J.
    Mannel, Robert S.
    Schilder, Jeanne M.
    Hunter, Mark I.
    McCourt, Carolyn K.
    Samuelson, Megan I.
    Leslie, Kimberly K.
    GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 507 - 512
12345